LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹21 Cr | ₹13 Cr | ₹12 Cr | ₹-47 Cr | ₹-21 Cr |
What is the latest Net Current Assets ratio of LYKA LABS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹-47 Cr |
| Mar2021 | ₹-21 Cr |
How is Net Current Assets of LYKA LABS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹21 Cr | 61.49 | |
| Mar2024 | ₹13 Cr | 10.99 | |
| Mar2023 | ₹12 Cr | Positive | |
| Mar2022 | ₹-47 Cr | Negative | |
| Mar2021 | ₹-21 Cr | - | |
Compare Net Current Assets of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹263.2 Cr | -6.9% | 14.9% | -37.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -6.9% |
14.9% |
-37.3% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses